Wanted: More Women to Become Financial Planners
A $12,000 Smartphone May Already Be in Your Pocket
Amazon to Turn Fan Fiction into a Money Maker with Kindle Worlds
NASDAQ: ATHX
Athersys Management Discusses Q2 2012 Results - Earnings Call Transcript
Athersys reports Q2 EPS (13c), consensus (14c)
Athersys Reports Second Quarter 2012 Results
University Hospitals Case Medical Center to Study Stem Cell Therapy for Stroke Treatment
Athersys to Host Second Quarter 2012 Financial Results Call
Athersys (ATHX) Gets Orphan Drug Designation For Hurler's Syndrome Therapy
Athersys (ATHX) MultiStem Granted Orphan Drug Designation by FDA for Hurler's Syndrome Treatment
Athersys receives orphan drug designation for MultiStem
Athersys Receives Orphan Drug Designation for MultiStem in Hurler's Syndrome
Athersys jumps 15c to $1.70 after FDA announces Orphan status for drug